Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer looking for participants, signaling that enrollment has closed. Added navigation and help items—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—along with a page revision note 'Revision: v3.6.0' to reflect updates to the study record layout.
    Difference
    0.4%
    Check dated 2026-06-12T11:40:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, reflecting a minor page version update. No study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2026-06-05T09:32:34.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page’s metadata.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:00.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page shows a revision tag that updates the version from v3.5.2 to v3.5.3, representing a minor update to the page; the core study details and layout remain the same.
    Difference
    0.1%
    Check dated 2026-04-30T16:31:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:10:24.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Waldenström macroglobulinemia is now listed as a condition on the page, and a Resources section has been added with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:22:27.000Z thumbnail image

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.